文献
J-GLOBAL ID:201702257191880727
整理番号:17A1465543
ステージIII結腸癌における経口アジュバント化学療法レジメンの腫瘍学的転帰:テガフール・ウラシルプラスロイコボリン対カペシタビン【Powered by NICT】
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine
著者 (8件):
Tashiro Jo
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Yamaguchi Shigeki
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Ishii Toshimasa
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Kondo Hiroka
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Hara Kiyoka
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Shimizu Hiroki
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Takemoto Kenichi
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
,
Suzuki Asami
(Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan)
資料名:
Clinical Colorectal Cancer
(Clinical Colorectal Cancer)
巻:
16
号:
3
ページ:
e141-e145
発行年:
2017年
JST資料番号:
W3205A
ISSN:
1533-0028
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)